These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 1093645)

  • 1. Immunotherapy in cancer of the larynx - an overview.
    Bone RC
    Can J Otolaryngol; 1975; 4(1):32-5. PubMed ID: 1093645
    [No Abstract]   [Full Text] [Related]  

  • 2. [Outlook for the use of antitumor vaccines in the treatment and prevention of malignant neoplasms].
    Shuklinov VA; Shumilina VV
    Vopr Onkol; 1985; 31(8):3-10. PubMed ID: 3898578
    [No Abstract]   [Full Text] [Related]  

  • 3. [Immunological status of laryngeal cancer patients and the problems of nonspecific immunotherapy].
    Nasretdinov TKh; Gorodilova VV; Pogosov VS; Akopian RG
    Vestn Otorinolaringol; 1981; (4):56-61. PubMed ID: 7303375
    [No Abstract]   [Full Text] [Related]  

  • 4. Antigenic epitopes of three tumor-associated antigens of well-differentiated squamous cell carcinoma of the larynx for use in monitoring patients in specific active immunochemotherapy trials.
    Hollinshead AC
    Cancer Detect Prev; 1987; 10(3-4):153-8. PubMed ID: 2436778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Attempt to produce antineoplastic immunity in children with laryngeal papillomatosis].
    Il'in KV; Chireshkin DG; Spure ZhZh
    Vestn Akad Med Nauk SSSR; 1971; 26(3):11-8. PubMed ID: 4931987
    [No Abstract]   [Full Text] [Related]  

  • 6. Chemo-immunotherapy and immunological study in carcinoma of larynx and laryngopharynx.
    Purohit JP; Dayal D; Kapoor AK; Khan IU
    J Indian Med Assoc; 1991 Aug; 89(8):219-21. PubMed ID: 1748797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotherapy for cancer: an overview.
    Proctor JW; Lewis MG; Mansell PW
    Can J Surg; 1976 Jan; 19(1):12-9. PubMed ID: 1145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laser surgery and immunotherapy in the management of laryngeal papilloma.
    Lyons GD; Schlosser JV; Lousteau R; Mouney DF; Benes EN
    Laryngoscope; 1978 Oct; 88(10):1586-8. PubMed ID: 703451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of tube LAI assay in larynx cancer patients.
    Hasek M; Holán V; Síbl O; Kousalová M
    Neoplasma; 1981; 28(6):685-8. PubMed ID: 7040994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Morphometric analysis of local immune reactions in the larynx of rats under the effect of methylcholanthrene].
    Kuznetsova IM
    Vopr Onkol; 1983; 29(3):71-7. PubMed ID: 6836991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overview of chemotherapy of cancer of the larynx.
    Nahum AM
    Can J Otolaryngol; 1975; 4(1):4-11. PubMed ID: 1131724
    [No Abstract]   [Full Text] [Related]  

  • 12. [Considerations on the treatment of cancer of the larynx].
    Portmann G; Traissac L; Bisch X
    Rev Laryngol Otol Rhinol (Bord); 1970; 91(1):16-31. PubMed ID: 5439214
    [No Abstract]   [Full Text] [Related]  

  • 13. [Results of immunotherapy treatment of severe infantile papillomas].
    Pinson L; Traissac L; Mattern P; Roche JC; Patris D
    Rev Laryngol Otol Rhinol (Bord); 1976; 97(9-10):371-7. PubMed ID: 1005974
    [No Abstract]   [Full Text] [Related]  

  • 14. [Cellular immunity in laryngeal cancer].
    Nasretdinov TKh; Pogosov VS; Gorodilova VV; Babakova SV; Ul'chenko VM
    Vestn Otorinolaringol; 1981; (2):55-8. PubMed ID: 7013242
    [No Abstract]   [Full Text] [Related]  

  • 15. [Preliminary note on a trial of active immunotherapy with B.C.G. for otorhinolaryngologic tumors].
    Amiel JL; Sancho H; Vandenbrouck C
    Bull Cancer; 1976; 63(2):287-8. PubMed ID: 990519
    [No Abstract]   [Full Text] [Related]  

  • 16. Laryngeal papilloma: review of etiology and therapy.
    Holinger PH; Schild JA; Maurizi DG
    Laryngoscope; 1968 Sep; 78(9):1462-74. PubMed ID: 5683706
    [No Abstract]   [Full Text] [Related]  

  • 17. [Immunologic study on patients with head and neck cancer treated with thymopentin associated with surgery, chemotherapy and radiotherapy].
    Denaro A; Stivala F; Mazzarino MC
    Acta Otorhinolaryngol Ital; 1994; 14(6):611-25. PubMed ID: 7740961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospects for the immunotherapy of cancer. Part II: current status of immunotherapy.
    Pilch YH; Myers GH; Sparks FC; Golub SH
    Curr Probl Surg; 1975 Feb; ():1-61. PubMed ID: 1092529
    [No Abstract]   [Full Text] [Related]  

  • 19. [Does an immune reactivity to human laryngeal cancer exist?].
    Cortesina G; Cavallo GP; Sartoris A; Beatrice F; Morra B; Bussi M; Poggio E
    G Batteriol Virol Immunol; 1979; 72(1-6):169-90. PubMed ID: 399929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laryngeal papillomatosis: immunologic and viral basis for therapy.
    Bone RC; Feren AP; Nahum AM; Windelhake BG
    Laryngoscope; 1976 Mar; 86(3):341-8. PubMed ID: 943680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.